Research Publications

Rieder F, Nagy LE, Maher TM, Distler JHW, Kramann R, Hinz B, Prunotto M. Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs. Nat Rev Drug Discov. 2025 May;24(5):399. doi: 10.1038/s41573-025-01190-9.PMID: 40164812

Abraham DJ, Black CM, Denton CP, Distler JHW, Domsic R, Feghali-Bostwick C, Gourh P, Hinchcliff M, Kolling F 4th, Kuwana M, Lafyatis R, Landegren U, Mahoney JM, Martin J, Matucci-Cerinic M, McMahan ZH, Mora AL, Mouthon L, Rabinovitch M, Rojas M, Rubin K, Trojanowska M, Varga J, Whitfield ML, Gabrielli A, Krieg T Publisher Correction: An international perspective on the future of systemic sclerosis research. Nat Rev Rheumatol. 2025 Apr;21(4):249. doi: 10.1038/s41584-025-01231-y.PMID: 40032952

Hong X, Xiao Y, Xu L, Shen L, Neelagar R, Devakumar V, Trinh-Minh T, Liang M, Rius Rigau A, Zhang Y, Li YN, Dees C, Györfi AH, Wolff D, Herr W, Schett G, Distler JHW, Matei AE. Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD. Blood Adv. 2025 Mar 25;9(6):1261-1266. doi: 10.1182/bloodadvances.2024014387.PMID: 39775728 

Györfi AH, Filla T, Polzin A, Tascilar K, Buch M, Tröbs M, Matei AE, Airo P, Balbir-Gurman A, Kuwert F, Mihai C, Kabala A, Graßhoff H, Callaghan J, Isomura Y, Mansour J, Spierings J, Tennoe AH, Selvi E, Riccieri V, Hoffmann-Vold AM, Bergmann C, Schett G, Hunzelmann N, van Laar JM, Saketkoo LA, Kuwana M, Siegert E, Riemekasten G, Distler O, du Four T, Smith V, Truchetet ME, Distler JHW; EUSTAR collaborators. Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort. J Am Heart Assoc. 2025 Mar 4;14(5):e036730. doi: 10.1161/JAHA.124.036730. Epub 2025 Feb 26.PMID: 40008525